Ticagrelor Use in Indian Patients Undergoing Neuroendovascular Procedures: A Single Center Experience

PURPOSE: A safe and efficacious antiplatelet drug is needed for patients with clopidogrel resistance who undergo neuroendovascular procedures. Ticagrelor is a new reversibly binding, oral, direct-acting P2Y receptor antagonist with no known resistance. We describe our clinical experience using ticag...

Descripción completa

Detalles Bibliográficos
Autores principales: Karan, Vivek, Vyas, Devashish, Bohra, Vikram, Huded, Vikram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Interventional Neuroradiology 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736500/
https://www.ncbi.nlm.nih.gov/pubmed/31387163
http://dx.doi.org/10.5469/neuroint.2019.00087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736500/
https://www.ncbi.nlm.nih.gov/pubmed/31387163
http://dx.doi.org/10.5469/neuroint.2019.00087

Ejemplares similares